Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

Interferon-induced gene expression in cervical mucosa during human papillomavirus infection.

Pierangeli A, Degener AM, Ferreri ML, Riva E, Rizzo B, Turriziani O, Luciani S, Scagnolari C, Antonelli G.

Int J Immunopathol Pharmacol. 2011 Jan-Mar;24(1):217-23.

PMID:
21496405
2.

Interferon lambda 1 expression in cervical cells differs between low-risk and high-risk human papillomavirus-positive women.

Cannella F, Scagnolari C, Selvaggi C, Stentella P, Recine N, Antonelli G, Pierangeli A.

Med Microbiol Immunol. 2014 Jun;203(3):177-84. doi: 10.1007/s00430-014-0330-9. Epub 2014 Feb 8.

PMID:
24510368
3.

IFN-κ, a novel type I IFN, is undetectable in HPV-positive human cervical keratinocytes.

DeCarlo CA, Severini A, Edler L, Escott NG, Lambert PF, Ulanova M, Zehbe I.

Lab Invest. 2010 Oct;90(10):1482-91. doi: 10.1038/labinvest.2010.95. Epub 2010 May 17.

4.

Human papillomavirus (HPV) DNA copy number is dependent on grade of cervical disease and HPV type.

Swan DC, Tucker RA, Tortolero-Luna G, Mitchell MF, Wideroff L, Unger ER, Nisenbaum RA, Reeves WC, Icenogle JP.

J Clin Microbiol. 1999 Apr;37(4):1030-4.

5.

Single-cell cytokine analysis allows detection of cervical T-cell responses against human papillomavirus type 16 L1 in women infected with genital HPV.

Passmore JA, Burch VC, Shephard EG, Marais DJ, Allan B, Kay P, Rose RC, Williamson AL.

J Med Virol. 2002 Jun;67(2):234-40.

PMID:
11992584
6.

Evaluation of type-specific HPV persistence and high-risk HPV viral load quantitation in HPV positive women under 30 with normal cervical cytology.

Carcopino X, Bolger N, Henry M, Mancini J, Boubli L, Olive D, Cleary S, Prendiville W, Tamalet C.

J Med Virol. 2011 Apr;83(4):637-43. doi: 10.1002/jmv.22022.

PMID:
21328378
7.

Detection, genotyping and quantitation of multiple hpv infections in south African women with cervical squamous cell carcinoma.

Lebelo RL, Bogers JJ, Thys S, Depuydt C, Benoy I, Selabe SG, Bida MN, Mphahlele MJ.

J Med Virol. 2015 Sep;87(9):1594-600. doi: 10.1002/jmv.24132. Epub 2015 Jun 2.

PMID:
26037775
8.

Cell-type specific interferon stimulated gene staining in liver underlies response to interferon therapy in chronic HBV infected patients.

Zhu Y, Qin B, Xiao C, Lu X, Chen L.

Dig Dis Sci. 2012 Sep;57(9):2355-61. doi: 10.1007/s10620-012-2169-5. Epub 2012 May 15.

PMID:
22585383
9.

Physical state and expression of HPV DNA in benign and dysplastic cervical tissue: different levels of viral integration are correlated with lesion grade.

Hudelist G, Manavi M, Pischinger KI, Watkins-Riedel T, Singer CF, Kubista E, Czerwenka KF.

Gynecol Oncol. 2004 Mar;92(3):873-80.

PMID:
14984955
10.

Human papillomavirus multiplex ligation-dependent probe amplification assay for the assessment of viral load, integration, and gain of telomerase-related genes in cervical malignancies.

Theelen W, Litjens RJ, Vinokurova S, Haesevoets A, Reijans M, Simons G, Smedts F, Herrington CS, Ramaekers FC, von Knebel Doeberitz M, Speel EJ, Hopman AH.

Hum Pathol. 2013 Nov;44(11):2410-8. doi: 10.1016/j.humpath.2013.04.026. Epub 2013 Aug 19.

11.

Interest of human papillomavirus DNA quantification and genotyping in paired cervical and urine samples to detect cervical lesions.

Ducancelle A, Legrand MC, Pivert A, Veillon P, Le Guillou-Guillemette H, De Brux MA, Beby-Defaux A, Agius G, Hantz S, Alain S, Catala L, Descamps P, Postec E, Caly H, Charles-Pétillon F, Labrousse F, Lunel F, Payan C.

Arch Gynecol Obstet. 2014 Aug;290(2):299-308. doi: 10.1007/s00404-014-3191-y. Epub 2014 Mar 13.

PMID:
24622934
12.

Th1 cytokine patterns in cervical human papillomavirus infection.

Scott M, Stites DP, Moscicki AB.

Clin Diagn Lab Immunol. 1999 Sep;6(5):751-5.

13.
14.

Local expression of interferon-alpha and interferon receptors in cervical intraepithelial neoplasia.

Tirone NR, Peghini BC, Barcelos AC, Murta EF, Michelin MA.

Cancer Immunol Immunother. 2009 Dec;58(12):2003-10. doi: 10.1007/s00262-009-0707-6. Epub 2009 Apr 18.

PMID:
19381629
15.

Viral load and genomic integration of HPV 16 in cervical samples from HIV-1-infected and uninfected women in Burkina Faso.

Rousseau MN, Costes V, Konate I, Nagot N, Foulongne V, Ouedraogo A, Van de Perre P, Mayaud P, Segondy M; Yerelon Study Group.

J Med Virol. 2007 Jun;79(6):766-70.

PMID:
17457905
16.

Physical status and expression of HPV genes in cervical cancers.

Park JS, Hwang ES, Park SN, Ahn HK, Um SJ, Kim CJ, Kim SJ, Namkoong SE.

Gynecol Oncol. 1997 Apr;65(1):121-9.

PMID:
9103401
17.

Human papilloma virus types in the oral and cervical mucosa of HIV-positive South African women prior to antiretroviral therapy.

Richter KL, van Rensburg EJ, van Heerden WF, Boy SC.

J Oral Pathol Med. 2008 Oct;37(9):555-9. doi: 10.1111/j.1600-0714.2008.00670.x. Epub 2008 Mar 19.

PMID:
18355174
18.

TLR9 is expressed in human papillomavirus-positive cervical cells and is overexpressed in persistent infections.

Cannella F, Pierangeli A, Scagnolari C, Cacciotti G, Tranquilli G, Stentella P, Recine N, Antonelli G.

Immunobiology. 2015 Mar;220(3):363-8. doi: 10.1016/j.imbio.2014.10.012. Epub 2014 Oct 23.

PMID:
25454809
19.

Differential viral loads of human papillomavirus 16 and 58 infections in the spectrum of cervical carcinogenesis.

Lai HC, Peng MY, Nieh S, Yu CP, Chang CC, Lin YW, Sun CA, Chu TY.

Int J Gynecol Cancer. 2006 Mar-Apr;16(2):730-5.

PMID:
16681753
20.

Proinflammatory and type 1 cytokine expression in cervical mucosa during HIV-1 and human papillomavirus infection.

Behbahani H, Walther-Jallow L, Klareskog E, Baum L, French AL, Patterson BK, Garcia P, Spetz AL, Landay A, Andersson J.

J Acquir Immune Defic Syndr. 2007 May 1;45(1):9-19.

PMID:
17356467

Supplemental Content

Support Center